McLeod Health CMIO on Choosing, Measuring ROI of Ambient AI Solution
Bryon Frost, M.D., CMIO of South Carolina-based hospital system, says shifting to utilization-based pricing from…
McLeod Health CMIO on Choosing, Measuring ROI of Ambient AI Solution
Bryon Frost, M.D., CMIO of South Carolina-based hospital system, says shifting to utilization-based pricing from a subscription model was the game-changer to unlock ROI
9 Pilots to Test Behavioral Health Data Standard Implementation
Pilots representing 45 exchange partners across nine states will inform future standards, technical specifications, and policy considerations
Eikon Therapeutics Continues the IPO Parade, Raising $381M for Cancer Drug Clinical Trials
Eikon Therapeutics’ IPO haul will support a lead program that could expand the scope of cancer immunotherapy. Eikon’s stock market debut builds on growing IPO momentum, following upsized offerings from Aktis Oncology and Veradermics. The post Eikon Therapeutics Continues the IPO Parade, Raising $381M for Cancer Drug Clinical Trials appeared first on MedCity News.
What the Health? From KFF Health News: HHS Gets Funding, But How Will Trump Spend It?
The Host Julie Rovner KFF Health News @jrovner @julierovner.bsky.social Read Julie’s stories. Julie Rovner is chief Washington correspondent and host of KFF Health News’ weekly health policy news podcast, “What the Health?” A noted expert on health policy issues, Julie is the author of the critically praised reference book “Health Care Politics and Policy A…
Potential Impacts of Trump Administration H-1B Visa Policies on the Health Care and Social Assistance Industries
This issue brief provides an overview of the H-1B visa program, analyzes trends in H-1B visa approvals for the health care and social assistance industries using data from the U.S. Citizenship and Immigration Services, and discusses potential implications of recent policies impacting the H-1B program on the U.S. health care workforce.
Debunked Episode 23: Companies Vie for Healthcare AI Dominance
The conversation between MedCity News Editor-in-Chief Arundhati Parmar and Samir Batra, managing partner of Health Innovation Pitch, highlighted news from the J.P. Morgan Healthcare Conference, particularly how technology and biopharma companies are shaping AI in healthcare. The post Debunked Episode 23: Companies Vie for Healthcare AI Dominance appeared first on MedCity News.
The Illusion of Diversion Data: Why Confirmed Diversion Counts Misrepresent True Risk
Confirmed diversion cases do not equal true prevalence – they are directly dependent on investigative proficiency, tooling, and the bandwidth of the teams doing the work. The post The Illusion of Diversion Data: Why Confirmed Diversion Counts Misrepresent True Risk appeared first on MedCity News.
Choosing the Right Methods for the Right AI to Accelerate Prior Authorizations
With regulatory scrutiny intensifying and the demand for speed, compliance, and clarity growing, understanding the nuanced differences between AI approaches is essential for payers, providers, and patients alike. The post Choosing the Right Methods for the Right AI to Accelerate Prior Authorizations appeared first on MedCity News.
Newsom ajusta su discurso sobre la salud de inmigrantes enfocado en una posible candidatura presidencial
El gobernador de California, Gavin Newsom, que aspira a presentarse en las elecciones presidenciales, ha enfurecido tanto a demócratas como a republicanos por su posición sobre la atención médica para los inmigrantes en su estado. La situación revela el delicado camino político que tiene por delante. Por segundo año, el demócrata pidió a los legisladores…
ACA Marketplace Enrollment is Down in 2026—But All of the Data Isn’t in Yet
This brief explains the limitations of early data in understanding the impact of the expiration of enhanced premiums tax credit on ACA enrollment. It also provides a timeline of when more complete data will become available.
